Accounting reportsPreviously
|
Name | TSENTR SOVREMENNOY MEDITSINY NOVOMED, OOO |
|---|
INN | 1326212556 |
|---|
KPP | 132601001 |
|---|
OGRN | 1091326002569 |
|---|
OKPO | 63970001 |
|---|
Address | 430030, Respublika Mordoviya, g Saransk, ul B.khmel'nitskogo, d. D. 83 |
|---|
Phone | +7 (927) 176-09-89 Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 86.10 | Core activity | Hospitals | | 21.1 | Additional activity | Pharmaceutical substances | | 21.10 | Additional activity | Manufacture of manmade fibres | | All types of activities | | 46.46 | Additional activity | Wholesale of pharmaceutical goods | | 46.9 | Additional activity | Wholesale trade in specialized stores | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | | 77.29.9 | Additional activity | Rental of other household goods and personal items for households, businesses and organizations, not included in other categories | | 77.39.26 | Additional activity | Rental and leasing of equipment, vehicles and other equipment used for medical purposes | | 86.21 | Additional activity | General practice | | 86.90.9 | Additional activity | Other independent activities in health care |
Registration date | 20.10.2009 |
|---|
Registering department | Inspektsiya Federal'noy nalogovoy sluzhby po Leninskomu rayonu g. Saranska |
|---|
|
NOVOMED, OOO (Mordovia, Republic; INN 1326212556) was registered on 20 Oct 2009. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of NOVOMED, OOO - Limited liability companies. Form of ownership of NOVOMED, OOO - Private property. Principal activities of NOVOMED, OOO: hospitals (86.10), pharmaceutical substances (21.1), manufacture of manmade fibres (21.10). |
Economic indicators2023
Net profit (RAS) of NOVOMED, OOO grew over 2023 2.07 times to 20.03 million RUB from 9.66 million RUB over 2022, the company informed. Revenue increased in the accounting period by 20.93% to 92.56 million RUB from 76.54 million RUB over 2022. 2022
Net profit (RAS) of NOVOMED, OOO dropped in 2022 by 48.51% to 9.66 million RUB from 18.76 million RUB over the same period in 2021, the company informed. Revenue decreased in the accounting period by 4.66% to 76.54 million RUB from 80.28 million RUB in 2021. 2021
Net profit (RAS) of NOVOMED, OOO grew over 2021 23.31 times to 18.76 million RUB from 805.00 thousand RUB over 2020, the company informed. Revenue increased in the accounting period by 11.75% to 80.28 million RUB from 71.84 million RUB over 2020. 2020
Net profit (RAS) of NOVOMED, OOO dropped in 2020 15.51 times to 805.00 thousand RUB from 12.48 million RUB over the same period in 2019, the company informed. Revenue decreased in the accounting period by 15.43% to 71.84 million RUB from 84.94 million RUB in 2019. 2019
Net profit (RAS) of NOVOMED, OOO dropped in 2019 by 5.88% to 12.48 million RUB from 13.26 million RUB over the same period in 2018, the company informed. Revenue increased in the accounting period by 8.78% to 84.94 million RUB from 78.08 million RUB over 2018. 2018
Net profit (RAS) of NOVOMED, OOO dropped in 2018 by 2.89% to 13.26 million RUB from 13.66 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 7.45% to 78.08 million RUB from 72.67 million RUB over 2017; cost of goods sold grew by 10.10% to 61.87 million RUB from 56.19 million RUB; sales profit fell by 1.56% to 16.22 million RUB from 16.47 million RUB. 2017
Net profit (RAS) of NOVOMED, OOO grew over 2017 by 20.94% to 13.66 million RUB from 11.29 million RUB over 2016, the company informed. Revenue increased in the accounting period by 6.01% to 72.67 million RUB from 68.55 million RUB over 2016; cost of goods sold grew by 2.92% to 56.19 million RUB from 54.60 million RUB; sales profit went up by 18.10% to 16.47 million RUB from 13.95 million RUB. 2016
Net profit (RAS) of NOVOMED, OOO grew over 2016 by 27.10% to 11.29 million RUB from 8.88 million RUB over 2015, the company informed. Revenue increased in the accounting period by 10.78% to 68.55 million RUB from 61.88 million RUB over 2015; cost of goods sold grew by 7.79% to 54.60 million RUB from 50.65 million RUB; sales profit went up by 24.27% to 13.95 million RUB from 11.23 million RUB. 2014
Net profit (RAS) of NOVOMED, OOO dropped in 2014 by 5.68% to 16.17 million RUB from 17.14 million RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 10.19% to 64.08 million RUB from 58.15 million RUB over 2013; cost of goods sold grew by 17.90% to 45.67 million RUB from 38.74 million RUB; sales profit fell by 5.18% to 18.41 million RUB from 19.42 million RUB. 2013
Net profit (RAS) of NOVOMED, OOO dropped in 2013 by 1.28% to 17.14 million RUB from 17.36 million RUB over the same period in 2012, the company informed. Revenue increased in the accounting period by 20.77% to 58.15 million RUB from 48.15 million RUB over 2012; cost of goods sold grew by 23.95% to 38.74 million RUB from 31.25 million RUB; sales profit went up by 14.89% to 19.42 million RUB from 16.90 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|